Eating disorders in patients with obesity and type 2 diabetes mellitus. Lecture for physicians
- Authors: Zelenkova-Zakharchuk T.A.1
-
Affiliations:
- Endocrinology Research Centre
- Issue: Vol 23, No 4 (2021)
- Pages: 326-331
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/95438
- DOI: https://doi.org/10.26442/20751753.2021.4.200830
- ID: 95438
Cite item
Full Text
Abstract
Obesity and type 2 diabetes mellitus (DM 2) that result from eating disorders (ED) which lead to weight gain are endocrine diseases provoked (caused) by psychopathology, and are psychosomatic diseases. The clinical features of ED in obesity and diabetes mellitus 2 are that they rarely occur as independent psychopathological units and are mainly represented by syndromic classification in the structure of other mental disorders. Preference of the predominant type of overeating for certain types of ED onset was revealed. Thus, fetal onset is characterized by permanent overeating, pubertal one - by compulsive overeating, psychogenic one - evening overeating and menopausal/age-related hypoandrogenic one - by polysyndromic overeating. Psychopharmacotherapy and psychotherapy combination is used to treat ED in patients with DM 2 and obesity. For prevention of obesity, it is recommended to diagnose early signs of ED which lead to weight gain, and to initiate psychiatric and psychotherapeutic care as soon as possible if ED occurred. Recent 2021 clinical guidelines for the treatment of obesity were updated with recommendation that all obese patients after secondary causes for weight gain were excluded, should be consulted by a psychiatrist-psychotherapist specializing in the general somatic network.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Tatyana A. Zelenkova-Zakharchuk
Endocrinology Research Centre
Email: tazach@mail.ru
канд. мед. наук, психиатр-психотерапевт Moscow, Russia
References
- Дедов И.И., Мельниченко Г.А., Шестакова М.В., и др. 3-й пересмотр клинических рекомендаций по лечению морбидного ожирения у взрослых. Ожирение и метаболизм. 2018;15(1):53-70
- Смулевич А.Б. Психические расстройства в клинической практике. М., 2016
- Малкина-Пых И.Г. Терапия пищевого поведения. М.: Эксмо, 2007
- Старостина Е.Г. Нетяжелые психические расстройства у больных сахарным диабетом. ConsiliumMedicum. 2011;13(12):35-40
- Бобров А.Е., Володина М.Н., Агамамедова И.Н., и др. Психические расстройства у больных сахарным диабетом 2-го типа. РМЖ. 2018;1(I):28-33
- Albayrak O, Hebebrand J. Eating Addiction - A Behavioral Addiction? Psychother Psychosom Med Psychol. 2015;65(1):39-41. doi: 10.1055/s-0034-1394412
- Scott CJ. Treatment of Binge Eating Disorder. Curr Treat Options Psychiatry. 2014;1:307-14. doi: 10.1007/s40501-014-0023-4
- Arnold LM, McElroy SL, Hudson JI, et al. A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder. J Clin Psychiatry. 2002;63:1028-33.
- Grilo CM, Masheb RM, Wilson GT. Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison. Biol Psychiatry. 2005;57:301-9.
- Hudson JI, McElroy SL, Raymond NC, et al. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial. Am J Psychiatry. 1998;155:1756-62.
- McElroy SL, Casuto LS, Nelson EB, et al. Placebo-controlled trial of sertraline in the treatment of binge eating disorder. Am J Psychiatry. 2000;157:1004-6.
- Guerdjikova AI, McElroy SL, Kotwal R, et al. High-dose escitalopram in the treatment of bingeeating disorder with obesity: a placebo-controlled monotherapy trial. Hum Psychopharmacol. 2008;23:1-11.
- Guerdjikova AI, McElroy SL, Winstanley EL, et al. Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial. Int J Eat Disord. 2012;45:281-9.
- Laederach-Hofmann K, Graf C, Horber F, et al. Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double-blind study. Int J Eat Disord. 1999;26(3):231-44.
- Bernstein BE, Bienenfeld D. Binge Eating Disorder (BED). Treatment & Management Mar 30, 2020. Available at:. https://emedicine.medscape.com/article/2221362-overview.
